






Glow
70mg
150.00$
Glow combines BPC‑157, TB‑500, and GHK‑Cu, making it of interest to researchers studying tissue response and extracellular matrix interactions. The inclusion of copper peptide GHK‑Cu is particularly valued for laboratory investigations into collagen and elastin synthesis models.
Glow
Product Name: Glow
Type: Synthetic Research Peptide Blend
Compound Composition:
• GHK-Cu – 50 mg
• TB-500 – 10 mg
• BPC-157 – 10 mg
Research Focus:
GLOW is a research peptide blend combining GHK-Cu, TB-500 (Thymosin Beta-4 fragment), and BPC-157 in one 70 mg vial. Each component has been studied for its regenerative and healing properties across various tissues[1][5]. By delivering all three in one formulation, GLOW aims to synergistically promote tissue repair, inflammation reduction, and wound healing beyond what each peptide might achieve alone.
Research Interest
• Wound healing and tissue regeneration models
• Skin re-modeling and extracellular matrix research
• Anti-inflammatory and vascular formation studies
Scientific Interest:
• Laboratory studies of extracellular matrix signaling
• Collagen and elastin research
• Tissue remodeling and cellular interaction studies
Reconstitution:
Reconstitute: Add 3.0 mLbacteriostatic water → ~23.3 mg/mLconcentration.
Typical daily dose: 2,330 mcg (2.33 mg) once daily for 4 weeks.
Easy measuring: At 23.3 mg/mL, 1 unit = 0.01 mL ≈ 233 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks.
Cycle:
Standard Approach (3 mL = 23.3 mg/mL)
WEEK | DAILY DOSE (MCG) | UNITS (PER INJECTION) (ML) |
|---|---|---|
Weeks 1–4 | 2,330 mcg | 10 units (0.10 mL) |
Frequency: Inject once dailysubcutaneously. This schedule maintains a consistent dose throughout the 4-week cycle, delivering approximately 1.7 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157 per injection. This once-daily regimen aligns with common research protocols for BPC-157 and similar repair peptides[5][6]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall to minimize foaming.
Gently swirl or roll the vial until fully dissolved (do not shake vigorously).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Use within 4 weeks for optimal potency and safety.
IMPORTANT NOTICE:
This product is intended strictly for laboratory research. It is not intended to diagnose, treat, cure, or prevent any disease.

